McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about when they typically invest.
Interviews/Contributions
A Conversation on Revolutionizing Vascular Surgery + Challenging the Medical Field with Dr. Frank J. Veith
Dr. Frank J. Veith and McDermott + Bull Partner Ken Dropiewski talk about the challenges in getting the medical field to adopt new procedures, the state of the vascular techniques he introduced to the industry, as well as an insider’s […]
Investor Insights: Geoff Pardo – What is Your Typical Investment Size? (Part 3)
McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde […]
Investor Insights: Geoff Pardo – How Do You See Venture in MedTech Looking In 2023? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what his team looks for in prospective partners in new venture opportunities.
Investor Insights: Geoff Pardo – How Do You See Venture in MedTech Looking In 2023? (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – Non-Traditional MedTech Services (Part 5)
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional MedTech services.
Investor Insights: Rob Barmann – What is Your Typical Investment Size? (Part 4)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about typical investment sizes in their portfolio companies.
Investor Insights: Rob Barmann – How Do You See Venture in MedTech Looking In 2023? (Part 3)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – What Do You Look for in New MedTech Ventures? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what his team looks for in prospective partners in new venture opportunities.
Investor Insights: Rob Barmann – Transitioning from Corporate Development to Venture Capital (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about his journey from corporate development to venture capital.
Recent
Popular
- No commented posts yet